X.T.L. Biopharmaceuticals Overview

X.T.L. Biopharmaceuticals Research & Development

Research & Development expenses for XTLB.

Quarterly R&D Expenses

$32000.00

↑ 433.33% YoY

As of Dec 31, 2024

Annual R&D Expenses (TTM)

$97999.00

↑ 216.13% YoY

Trailing 12 months ending Dec 31, 2024

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin